0001818794-20-000001.txt : 20200814 0001818794-20-000001.hdr.sgml : 20200814 20200813174637 ACCESSION NUMBER: 0001818794-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200814 DATE AS OF CHANGE: 20200813 EFFECTIVENESS DATE: 20200814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dyne Therapeutics, Inc. CENTRAL INDEX KEY: 0001818794 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364883909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-373216 FILM NUMBER: 201100478 BUSINESS ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 786-8230 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 D 1 primary_doc.xml X0708 D LIVE 0001818794 Dyne Therapeutics, Inc. 830 WINTER STREET WALTHAM MA MASSACHUSETTS 02451 (781) 786-8230 DELAWARE None None Corporation true 2017 Joshua Brumm 830 Winter Street Waltham MA MASSACHUSETTS 02451 Executive Officer Director Romesh Subramanian, Ph.D. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Executive Officer Oxana Beskrovnaya, Ph.D. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Executive Officer Jonathan McNeill, M.D. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Executive Officer Richard Scalzo 830 Winter Street Waltham MA MASSACHUSETTS 02451 Executive Officer Jason Rhodes 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Edward Hurwitz 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Dirk Kersten 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Lawrence Klein, Ph.D. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director David Lubner 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Catherine Stehman-Breen, M.D. 830 Winter Street Waltham MA MASSACHUSETTS 02451 Director Biotechnology Decline to Disclose 06b false 2020-08-07 false true false 0 115699984 115699984 0 false 19 0 0 0 false Dyne Therapeutics, Inc. /s/ Joshua Brumm Joshua Brumm President and Chief Executive Officer 2020-08-13